Hypermethylation of the FMR1 promoter leading to impaired FMR1 gene expression and subsequently loss of FMRP expression are hallmarks of FXS, leading to symptoms characteristic of this disorder. This evidence concerns the gene FMR1 and fragile X syndrome.